NSTEMI (Non-ST-segment elevation myocardial infarction)

Find all the latest content on NSTEMI published on this website.

NSTEMI is considered one of the leading causes of morbidity and mortality and its definition and treatment remains challenging requiring specific, adapted responses. Understanding different biomarkers, becoming aware of emerging new agents used in adjunctive pharmacotherapy, keeping abreast of advances in imaging techniques as well as the use of invasive imaging and functional assessment is critical. Tools, devices and techniques, and complications such as different types of vascular access or bleeding risks, can also be found here…

Filtered By
NSTEMI

293 results

PCRonline @ ACC.25 Scientific Sessions

07 Feb 2025

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2025 Scientific Sessions #ACC25

PCRonline @ ACC.25 Scientific Sessions

Percutaneous vs. Surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: The SWEDEHEART registry

02 Jan 2025

This registry-based observational study compares surgical and percutaneous revascularization in patients with multivessel disease who underwent treatment for non-ST-segment elevation myocardial infarction (NSTEMI), utilizing data extracted from the SWEDEHEART registry.

Reviewer

Ali Nazmi Calik

Reviewer

Murat Gökalp
Percutaneous vs. Surgical revascularization of NSTEMI with multivessel disease: The SWEDEHEART registry

When complications storm through the cathlab #2

19 Dec 2024 – From GulfPCR-GIM 2024

Brace yourself as we delve into a captivating session showcasing a series of complex and challenging complications that can arise in the catheterization laboratory. From a coiling gone awry to a stuck burr in an elderly patient, this session offers invaluable insights and strategies for navigating...

When complications storm through the cathlab #2

Interventional pot pourri #2

19 Dec 2024 – From GulfPCR-GIM 2024

This interventional potpourri session covers a diverse range of challenging cases in interventional cardiology. From a case of failed balloon angioplasty in a non-dilatable calcified lesion to an innovative approach for treating isolated side branch osteal lesions, this session offers valuable insights and practical solutions. Discover...

Interventional pot pourri #2

Interventional pot pourri #1

19 Dec 2024 – From GulfPCR-GIM 2024

Dive into this 'Interventional potpourri' session for a diverse array of captivating case studies and innovative techniques in interventional cardiology. Explore an anomalous right coronary artery origin, tackle a complex and poorly understood lesion, discover the integration of artificial intelligence in stentless PCI, and master the...

Interventional pot pourri #1

Best abstracts session #1

18 Dec 2024 – From GulfPCR-GIM 2024

Join us for this dynamic 'Best Abstracts' session, where we delve into the latest research and insights from the world of interventional cardiology. Explore a diverse range of topics, from the use of E/e ratio as a marker for predicting periprocedural myocardial infarction in diabetic patients,...

Best abstracts session #1

The DCB kissing technique as a durable solution in treatment of recurring left main in-stent restenosis

18 Nov 2024

A 73-year-old male with complex recurrent in-stent restenosis of the left main underwent an innovative treatment approach. Six-month follow-up revealed remarkable recovery and positive remodelling. Discover how Piotr Buszman and Mateusz Kachel tackled this challenging case.

#div-gpt-pcro_sidebar_topic {display:none !important;}
Piotr Buszman

Author

Piotr Buszman

Author

Mateusz Kachel
The DCB kissing technique as a durable solution in treatment of recurring left main in-stent restenosis

Hybrid procedure: Stent and DCB for a long diffuse lesion - LIVE case

05 Oct 2024 – From AICT-AsiaPCR 2024

A 40-year-old male with no comorbidities presented an NSTEMI. The angiography showed a focus lesion on the mid-CX and a diffuse lesion on the mid and distal LAD. The LAD FFR are 0.49 with a diffuse pullback gradient.
After Stent in mid-CX guided by OCT, the operators...

Hybrid procedure: Stent and DCB for a long diffuse lesion - LIVE case

Complex NSTEMI interventions: Bifurcation and calcification management strategies

05 Oct 2024 – From AICT-AsiaPCR 2024

Explore a diverse array of challenging NSTEMI cases in this session, curated from the AICT-AsiaPCR 2024 conference. Witness innovative approaches to managing bifurcation lesions, tackling calcified and complex coronary anatomy, and navigating double complications. Gain valuable insights from experienced interventionalists as they share their strategies for...

Complex NSTEMI interventions: Bifurcation and calcification management strategies

Breakthrough studies: Key abstracts on PCI, TAVI and mitral valve repair

04 Oct 2024 – From AICT-AsiaPCR 2024

Discover the cutting-edge research and innovative solutions presented in the 'Best Abstracts of AICT-AsiaPCR 2024' session. This curated selection showcases the latest advancements in interventional cardiology, from groundbreaking comparisons of transcatheter mitral valve repair techniques to the impact of cerebral embolic protection devices in TAVI procedures....

Breakthrough studies: Key abstracts on PCI, TAVI and mitral valve repair

Best clinical cases: Stent degloving, valve defects, and calcified lesions

04 Oct 2024 – From AICT-AsiaPCR 2024

Immerse yourself in a captivating collection of best clinical cases from AICT-AsiaPCR 2024. Witness the ingenuity and expertise of interventional cardiologists as they navigate complex scenarios, from addressing stuck prosthetic mitral valves to managing unconventional calcified lesions. Discover unique approaches, innovative solutions, and valuable lessons that...

Best clinical cases: Stent degloving, valve defects, and calcified lesions

Latest advances in interventional cardiology: Top abstracts on TAVI, PCI, and mitral valve repair

04 Oct 2024 – From AICT-AsiaPCR 2024

Discover the cutting-edge research and innovative solutions presented in the 'Best Abstracts of AICT-AsiaPCR 2024' session. This curated selection showcases the latest advancements in interventional cardiology, from groundbreaking comparisons of transcatheter mitral valve repair techniques to the impact of cerebral embolic protection devices in TAVI procedures....

Latest advances in interventional cardiology: Top abstracts on TAVI, PCI, and mitral valve repair

NSTEMI case studies: Innovative solutions for calcified lesions and coronary leaks

04 Oct 2024 – From AICT-AsiaPCR 2024

Dive into this comprehensive NSTEMI session, featuring a selection of compelling clinical case submissions from AICT-AsiaPCR 2024. Explore various challenging scenarios, including the management of calcified coronary interventions, plugging leaks, addressing severe calcified lesions with rotational atherectomy, and navigating refractory in-stent restenosis. Discover innovative approaches and...

NSTEMI case studies: Innovative solutions for calcified lesions and coronary leaks

IVORY FINALE study: Low-dose interleukin-2 for the reduction of vascular inflammation in ACS - Clinical outcomes and follow-up

31 Aug 2024

Aaysha Cader interviews Rouchelle Sriranjan about the results of the IVORY and IVORY 2 trials which she presented at the ESC Congress 2024 in London.

The trials examined low-dose interleukin-2 therapy to reduce arterial inflammation in acute coronary syndrome patients. The study found a 7.7% reduction in arterial inflammation...

Author

Aaysha Cader
Rouchelle Sriranjan

Author

Rouchelle Sriranjan

Effect of colchicine on coronary plaque stability in acute coronary syndrome as assessed by optical coherence tomography: the COLOCT randomized clinical trial

27 Aug 2024

The rationale for this study was to provide direct evidence of colchicine's effects on plaque stabilization, particularly by assessing changes in plaque characteristics using optical coherence tomography (OCT).

Giovanni Occhipinti

Reviewer

Giovanni Occhipinti

Reviewer

Salvatore Brugaletta
Effect of colchicine on coronary plaque stability in acute coronary syndrome as assessed by optical coherence tomography: the COLOCT randomized clinical trial

SENIOR-RITA - Older patients with non-ST segment elevation myocardial infarction randomised interventional treatment trial

02 Sep 2024

Mirvat Alasnag provides her take on the SENIOR-RITA trial, presented by Vijay Kunadian at the ESC Congress 2024 in London.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
SENIOR-RITA

Completeness of revascularisation in acute coronary syndrome patients with multivessel disease

28 Jun 2024

Explore evidence on complete revascularisation for patients with STEMI or NSTEMI and multivessel disease, and provide insights into the roles of intracoronary guidance by physiology and imaging.

Completeness of revascularisation in acute coronary syndrome patients with multivessel disease

Durable-polymer versus biodegradable-polymer drug-eluting stents in acute coronary syndromes: three-year outcomes of the HOST REDUCE POLYTECH RCT Trial

20 Jun 2024

This trial found that, in ACS patients undergoing PCI, DP-DES and BP-DES had similar patient-oriented outcomes at three years, but BP-DES had higher device-oriented composite outcomes, mainly due to increased TLR risk.

Nicola Ryan

Reviewer

Nicola Ryan
Durable polymer vs biodegradable polymer DES in ACS 3 year outcomes HOST REDUCE POLYTECH RCT Trial

Intravascular ultrasound vs angiography-guided drug-coated balloon angioplasty: the ULTIMATE III trial

13 Jun 2024

The results of this study show that IVUS guidance is associated with less late lumen loss compared to angiography guidance in HBR patients undergoing DCB angioplasty.

Nicola Ryan

Reviewer

Nicola Ryan
Intravascular ultrasound vs angiography-guided drug-coated balloon angioplasty: the ULTIMATE III trial

One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes

03 Jun 2024

The optimal duration of short DAPT in ACS patients is unknown, therefore this analysis of the XIENCE Short DAPT programme compared the clinical outcomes of one versus three months DAPT in HBR patients with and without ACS.

Nicola Ryan

Reviewer

Nicola Ryan
One- versus three-month DAPT in HBR patients undergoing PCI for non-ST-segment elevation ACS